ArticleMolecules (Basel, Switzerland)2024
Anticancer Effects of Abietane Diterpene 7α-Acetoxy-6β-hydroxyroyleanone from
Vera M S Isca, Przemysław Sitarek, Anna Merecz-Sadowska, Magdalena Małecka, Monika Owczarek, Joanna Wieczfińska, Radosław Zajdel, Paweł Nowak, Patricia Rijo, Tomasz Kowalczyk
Abstract read
In one paragraphArticle in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
10 authors.
Vera M S IscaCenter for Research in Biosciences & Health Technologies (CBIOS), Universidade Lusófona de Humanidades e Tecnologias, 1749-024 Lisbon, Portugal.ORCID 0000-0002-9045-7287 Przemysław SitarekDepartment of Medical Biology, Medical University of Lodz, Muszynskiego 1, 90-151 Lodz, Poland.ORCID 0000-0001-5495-3550 Anna Merecz-SadowskaDepartment of Economic and Medical Informatics, University of Lodz, 90-214 Lodz, Poland.ORCID 0000-0001-9987-4573 Magdalena MałeckaDepartment of Physical Chemistry, Faculty of Chemistry, University of Lodz, Pomorska 163/165, 90-236 Lodz, Poland.ORCID 0000-0003-3384-9855 Monika OwczarekŁukasiewicz Research Network, Lodz Institute of Technology, Skłodowskiej-Curie 19/27, 90-570 Lodz, Poland.ORCID 0000-0003-3758-150X Joanna WieczfińskaDepartment of Immunopathology, Medical University of Lodz, Zeligowskiego 7/9, 90-752 Lodz, Poland.ORCID 0000-0002-8830-1507 Radosław ZajdelDepartment of Economic and Medical Informatics, University of Lodz, 90-214 Lodz, Poland.ORCID 0000-0002-1654-8957 Patricia RijoCenter for Research in Biosciences & Health Technologies (CBIOS), Universidade Lusófona de Humanidades e Tecnologias, 1749-024 Lisbon, Portugal.ORCID 0000-0001-7992-8343 Tomasz KowalczykDepartment of Molecular Biotechnology and Genetics, Faculty of Biology and Environmental Protection, University of Lodz, Banacha 12/16, 90-237 Lodz, Poland.ORCID 0000-0002-4559-5015 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
The abietane diterpenoid 7α-acetoxy-6β-hydroxyroyleanone (Roy) isolated from
Indexed as
AbietanesDiterpenesMolecular Docking SimulationPlectranthusAntineoplastic AgentsAntineoplastic Agents, PhytogenicCell Line, TumorComputer SimulationHumansMolecular Dynamics SimulationMolecular Structure7alpha-acetoxy-6beta-hydroxyroyleanoneAbietanesAntineoplastic AgentsAntineoplastic Agents, PhytogenicDiterpenes7α-acetoxy-6β-hydroxyroyleanoneanticancer activityPlectranthus grandidentatus
Identifiers
PMID38675627
PMCPMC11052076
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390